Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. Oktober 2025 03:00 ET | Quelle: Swarm Oncology Ldd

Swarm Oncology announces research collaboration with a leading hospital to advance T cell therapies for advanced solid cancers

London, United Kingdom October 28, 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “Swarm”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with...
08. Mai 2025 02:00 ET | Quelle: Swarm Oncology Ldd

Swarm Oncology to present at Bio€quity Europe 2025

London, U.K., May 8 2025, Swarm Oncology Ltd. (“Swarm Oncology” or “the Company”), a biotechnology company pioneering novel T cell therapies to achieve long-term remission in patients with advanced...
27. Januar 2025 03:00 ET | Quelle: Swarm Oncology Ldd

Swarm Oncology Unveils Highly Differentiated, Personalised T Cell Therapy Platform to Significantly Improve Treatment Outcome for Cancer Patients and Appoints Martin Olin as Chief Executive Officer

Swarm Oncology co-founded by renowned T cell therapy manufacturing expert and immunologist Professor John Campbell, and mission-driven investor, Delin VenturesCompany is developing novel potent T cell...